Product Design, Manufacturing & Innovation Resources
» プロインスリン処理とインスリン生合成

プロインスリン処理とインスリン生合成

1967
  • Donald F. Steiner
Researcher studying proinsulin processing in a laboratory for cell biology applications.

(画像はイメージです)

Insulin is synthesized in pancreatic beta cells as a single-chain precursor called proinsulin. In the endoplasmic reticulum, proinsulin folds and forms its disulfide bonds. It is then transported to the Golgi apparatus and packaged into secretory granules, where proteases (prohormone convertases PC1/3 and PC2, and carboxypeptidase E) cleave it into mature insulin and a connecting peptide, C-peptide.

The discovery of proinsulin by Donald F. Steiner in 1967 resolved a key puzzle in insulin biosynthesis. It was known that insulin consisted of two separate polypeptide chains (A and B), but the mechanism for ensuring their coordinated synthesis and correct assembly via disulfide bonds was unclear. Steiner’s research revealed that a single gene codes for a larger, single-chain precursor. This preproinsulin molecule contains a signal peptide at its N-terminus that directs it into the lumen of the endoplasmic reticulum (ER). The signal peptide is quickly cleaved off, leaving proinsulin. Proinsulin consists of the B chain, a connecting C-peptide, and the A chain, in that order (B-C-A). Within the ER, the molecule folds into its proper conformation, guided by chaperones, which brings the cysteine residues into proximity, allowing the three crucial disulfide bonds to form correctly. This folded proinsulin is then transported to the Golgi complex and packaged into immature clathrin-coated secretory vesicles. As these vesicles mature into dense-core secretory granules, the internal environment becomes more acidic, activating specific endoproteases. Prohormone convertase 1/3 (PC1/3) makes the initial cut at the B-chain/C-peptide junction, and prohormone convertase 2 (PC2) cuts at the C-peptide/A-chain junction. Finally, carboxypeptidase E (CPE) trims off basic amino acid residues at the new C-termini, resulting in the final, mature two-chain insulin molecule and the free C-peptide. Both are stored in these granules and co-secreted in equimolar amounts in response to high blood glucose.

UNESCO Nomenclature: 2403
細胞生物学

タイプ

生物学的プロセス

混乱

実質的な

使用法

広く普及している

前駆物質

  • discovery of the protein synthesis pathway (ribosomes, er, golgi)
  • determination of insulin’s two-chain structure by sanger
  • development of pulse-chase labeling techniques using radioactive amino acids
  • identification of proteolytic enzymes (proteases)

アプリケーション

  • measurement of c-peptide levels in blood to assess endogenous insulin production
  • understanding of congenital hyperproinsulinemia, a genetic disorder of proinsulin processing
  • development of single-chain insulin analogs for improved stability
  • research into protein folding and trafficking within the cell
  • providing a model system for the biosynthesis of other peptide hormones

特許:

NA

潜在的なイノベーションのアイデア

ボットによるトラフィック(現在1日あたり4万件以上)を排除するため、このコンテンツはコミュニティメンバー限定となっています。
> ログイン < または > 登録 < (100%無料)でこれにアクセスできます。他のすべての制限付きコンテンツとツールも同様です。

Related to: proinsulin, c-peptide, biosynthesis, beta cell, endoplasmic reticulum, golgi apparatus, secretory granule, protein folding, post-translational modification, donald steiner.

歴史的背景

プロインスリン処理とインスリン生合成

1950
1954
1960
1967
1970
1975
1977
1950
1951
1958
1960
1970
1973
1975
1979

(日付が不明または関連性がない場合、例えば「流体力学」などでは、その注目すべき出現時期の概算値が提示されます。)

関連する発明、革新、および技術原理

フルサイズの画像とダウンロードは、登録会員のみが100%無料で利用できます。